A pharma-led guide to testing for chronic inflammation: what hs-CRP, ESR, and homocysteine measure, how to read the ranges, the chronic-vs-acute distinction, and what the evidence says to do if levels are elevated.

How chronic inflammatory cytokines like IL-6 and TNF-alpha interact with the brain to heighten anxiety, what the cohort research shows, and where GABA, 5-HTP, and resveratrol genuinely fit.

Why new hip pain in perimenopause is often driven by estrogen loss and soft-tissue inflammation, not worn cartilage. The trochanteric-pain mechanism, the boswellia and curcumin evidence, and honest limits — with real citations.

Estrogen restrains the master inflammatory switch NF-κB. As estrogen declines through menopause, NF-κB activity rises and inflammatory signaling turns up body-wide — which is why joint pain, brain fog, weight gain, and mood changes cluster together. The mechanism, the markers, and honest guidance, with real citations.

Maria Lanzieri on perimenopause belly weight as a signaling problem, not a willpower one: how falling estrogen drives visceral fat and NF-kappaB inflammation, and what genuinely helps.

Two Italian trials — Caruso 1990 (double-blind, placebo-controlled, n=50) and Sarzi Puttini 1992 (90-day open-label, n=200) — tested 5-HTP in fibromyalgia patients. Here's what the research actually found, the design limitations, and why serotonin's role in descending pain modulation is more important than its mood association.

Inflammaging is the chronic, low-grade inflammatory baseline that rises with age and underlies cardiovascular disease, type 2 diabetes, neurodegeneration, and sarcopenia. Fabio Lanzieri — 40 years in pharma — explains the Franceschi and Furman research and what you can actually do about it.

Why new joint pain, brain fog, gut changes, and fatigue in perimenopause share one root: rising inflammatory load as estrogen declines. The estradiol-CRP-IL-6 connection, mapped to symptoms, with honest guidance and real citations.

Morning stiffness and menopausal joint pain share a root cause: estrogen withdrawal raises inflammatory cytokines. These eight supplements have the strongest research behind them.

What the inflammatory cascade is, how it works step by step, and why chronic activation drives most modern disease. Clear, researcher-grade explanation.

A pharma-led comparison of Boswellia serrata and celecoxib (Celebrex) for knee osteoarthritis, with an honest reading of the 24-week Chopra equivalence trial and the 5-LOX vs. COX-2 mechanism distinction.

A pharmacist's-eye read of the Shep 2019 head-to-head RCT: standardized curcumin matched diclofenac on knee-osteoarthritis pain over 28 days with far fewer GI side effects (0% vs 28% needing H2 blockers). Honest framing on non-inferiority, the absorption caveat, and why this is a doctor conversation.

A mechanism explainer on piperine (black pepper extract): how it raised curcumin bioavailability 2,000%, enhances resveratrol absorption, and quiets the NF-kB inflammation pathway directly.

A pharmacist's-eye comparison of boswellia and ibuprofen: boswellic acids inhibit the 5-LOX/leukotriene pathway while ibuprofen inhibits COX/prostaglandins. Why they are complementary, not interchangeable, and what seven RCTs of boswellia for osteoarthritis actually found.

A pharmacist's-eye answer to how much curcumin to take for inflammation: the 120-1,500 mg studied range, the practical 500 mg twice-daily target, why standardization and piperine co-administration decide whether the dose actually arrives.

Turmeric is the root; curcumin is the active compound inside it. Why the curcuminoid percentage and curcumin's poor bioavailability mean standardized extract plus an absorption strategy is what the research is actually about.

Most gut-health content talks about probiotics and skips the cells holding the barrier together. L-glutamine is the primary metabolic fuel for enterocytes — the epithelial cells that form your intestinal lining. Here's the biology, the evidence, and where supplementation honestly fits.

Resveratrol activates the longevity pathway most supplements miss. What the SIRT1 research actually shows — and what dose actually moves the needle.

Forty years in pharma taught me to be careful with 'natural alternative' to ibuprofen. Here's when curcumin can stand in for daily NSAIDs — and when it can't.

Boswellia blocks 5-LOX. Turmeric targets COX-2. They hit different inflammatory pathways — here's when each wins and when you need both.

Chronic low-grade inflammation drives fatigue through the cytokine-induced sickness-behavior pathway. What the research shows about why you are always tired, and where Panax ginseng and matcha genuinely fit.

How falling estrogen affects the serotonin system in perimenopause, what 5-HTP (and its B6 cofactor) actually supports for mood, and why the research does not support a hot flash claim.

After 40 years in pharma, Fabio Lanzieri reads the ginseng fatigue trials: a 2022 meta-analysis of 12 RCTs (1,298 patients) shows a small but real benefit for disease-related fatigue, the ginsenoside and HPA-axis mechanism, and an honest look at where it beats placebo and where it doesn't.

How 5-HTP supports sleep through the serotonin-to-melatonin pathway, why it is not a sedative, what the human sleep research actually shows, and how the B6 cofactor fits in.

Perimenopausal mood swings are a neurochemical event, not a personality change. How estrogen decline drives inflammation and strains serotonin and GABA — and what the research suggests about 5-HTP, GABA, Panax ginseng, and vitamin B6.

Cristina Lanzieri tackles the blood-brain-barrier debate head-on: what oral GABA actually does for anxiety and stress, the gut-brain pathway, the placebo-controlled human studies (Abdou 2006, Yoto 2012), the honest limits, and how nervous-system hyperactivation and inflammation run together.

Maria Lanzieri on why perimenopause causes the 3 a.m. wake-up: how falling estrogen and progesterone and rising inflammation disrupt sleep, and what GABA, 5-HTP, and L-serine each actually do.

Perimenopause fatigue is a metabolic and inflammatory event, not a willpower problem. How estrogen decline raises IL-6 and strains the HPA axis and mitochondria — and what the research suggests about Panax ginseng, resveratrol, L-serine, and GABA.

Inflammation has two phases, not one. The resolution of acute inflammation is an active, programmed second wave governed by specialized pro-resolving mediators — resolvins, protectins, and maresins — derived from omega-3 fatty acids. Fabio Lanzieri explains the biology and what it means for what you eat.

7 evidence-backed supplements for menopause bloating, plus why estrogen decline drives gut inflammation and what you can actually do about it.